
Peptihans G 1mg/500mg Tablet PR
Marketer
Caligen Labs Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Peptihans G 1mg/500mg Tablet PR
Diabetic medication, Glucovance (a hypothetical equivalent to Peptihans G 1mg/500mg Tablet PR), combines two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Administer Glucovance with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to complications including kidney impairment, vision loss, neuropathy, and limb damage. Remember, Glucovance is one component of a comprehensive diabetes management plan, encompassing a balanced diet, exercise, and weight management as recommended by your doctor. Commonly, Glucovance can cause hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, trembling—and how to counteract them. Maintain regular eating patterns and carry readily available glucose sources like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Glucovance is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires prior medical evaluation. Regular blood glucose monitoring is essential, and your doctor might order blood tests to track blood cell counts and liver function.
Primary Ingredients of Peptihans G 1mg/500mg Tablet PR
There is no text provided to rephrase.
Uses of Peptihans G 1mg/500mg Tablet PR
Managing type 2 diabetes
Major Benefits of Peptihans G 1mg/500mg Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidance. Administer Peptihans G 1mg/500mg Tablet PR with a meal.
Common Side effects of Peptihans G 1mg/500mg Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Peptihans G 1mg/500mg Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidance. Administer Peptihans G 1mg/500mg Tablet PR with a meal.
How Peptihans G 1mg/500mg Tablet PR works:
Peptihans G tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in tissues.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Peptihans G 1mg/500mg Tablet PR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Peptihans G 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingUNSAFE
Use of Peptihans G 1mg/500mg tablets during lactation is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.
KidneyCAUTION
Patients with kidney impairment should use Peptihans G 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Peptihans G 1mg/500mg Tablet PR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Peptihans G 1mg/500mg Tablet PR cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. A reduced initial dose of Peptihans G 1mg/500mg Tablet PR is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Peptihans G 1mg/500mg Tablet PR :
For Peptihans G 1mg/500mg Tablet PR, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Peptihans G 1mg/500mg Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
